Patent · US Active

Quinazoline derivative

US10774079B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. · CN

Inventors

Ying Shi · Shijiazhuang, CN
Qingzhi Gao · Shijiazhuang, CN
Xiaozhuo Chen · Athens, US
Yi Mi · Shijiazhuang, CN
Yaran Zhang · Shijiazhuang, CN
Hanyu Yang · Xiong County, CN
Yujie Chen · Shanghai, CN
Chunlei Liu · Shanghai, CN
Guorui MI · Shijiazhuang, CN
Yuxiu Ma · Shijiazhuang, CN
Dongmin Shen · Xiong County, CN
Yang Guo · Shijiazhuang, CN
Linjing Fan · Shijiazhuang, CN

Key dates

Filing date	Aug 8, 2019
Grant date	Sep 15, 2020
Priority date	—
Expiry date	Aug 8, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.